Does insulin resistance influence white matter lesions in non-diabetic AD subjects?
Femminella, Grazia Daniela Wang, Yi-Ting van der Doef, Thalia Frangou, Eleni Love, Sharon Calsolaro, Valeria Carver, Stefan Holmes, Clive Ritchie, Craig W. Lawrence, Robert M.
Femminella, Grazia Daniela
Wang, Yi-Ting
van der Doef, Thalia
Frangou, Eleni
Love, Sharon
Calsolaro, Valeria
Carver, Stefan
Holmes, Clive
Ritchie, Craig W.
Lawrence, Robert M.
Abstract
Background: Vascular risk factors like hypertension, hyperlipidemia and diabetes mellitus are risk factors for Alzheimer's disease (AD). White matter lesions (WMLs) have been recognized as the imaging characteristics of cerebral small vessel diseases. WMLs are a risk factor for stroke, cognitive decline, and dementia and their prevalence increases with age. In magnetic resonance imaging (MRI), white matter hypointensities in T1-weighted images, and white matter hyperintensities in T2-weighted and FLAIR images are regarded as visualizations of WMLs. Peripheral insulin resistance (IR) may contribute to the etiopathogenesis of AD. Here we evaluated whether insulin resistance exerts its effects on non-diabetic AD subjects by influencing WMLs.
Method(s): 121 AD subjects form the Evaluating Liraglutide in Alzheimer's Disease (ELAD) trial (NCT01843075) were enrolled. Glucose and insulin levels were measured after a 4-hour fast on the day of the visit for the brain MRI. Insulin resistance was calculated by the homeostatic model assessment (HOMA-IR). Hypointensity volumetrics determined as WMLs were estimated using the FreeSurfer analysis (http://surfer.nmr.mgh.harvard.edu/) on T1 MRI acquired on 3T scans. Glucose metabolism (rCMRGlc) was calculated by parametric images generated using spectral analysis with an arterial plasma input function.
Result(s): In this non-diabetic AD population, the prevalence of IR was about 16%. WMLs volume was not correlated to HOMA-IR. However, WMLs was negatively correlated with left hippocampal volume (Spearman's rho=-.208, p=.02). WMLs volume was positively correlated with age and with serum triglyceride levels and negatively correlated with serum HDL cholesterol levels.
Conclusion(s): In this study in a non-diabetic AD population, white matter lesions were not correlated with peripheral insulin resistance. This suggests that in non-diabetic AD subjects, vascular changes are not influenced by peripheral insulin resistance.
Copyright © 2019 RN - 50-99-7 (glucose); 84778-64-3 (glucose); 204656-20-2 (liraglutide)
Method(s): 121 AD subjects form the Evaluating Liraglutide in Alzheimer's Disease (ELAD) trial (NCT01843075) were enrolled. Glucose and insulin levels were measured after a 4-hour fast on the day of the visit for the brain MRI. Insulin resistance was calculated by the homeostatic model assessment (HOMA-IR). Hypointensity volumetrics determined as WMLs were estimated using the FreeSurfer analysis (http://surfer.nmr.mgh.harvard.edu/) on T1 MRI acquired on 3T scans. Glucose metabolism (rCMRGlc) was calculated by parametric images generated using spectral analysis with an arterial plasma input function.
Result(s): In this non-diabetic AD population, the prevalence of IR was about 16%. WMLs volume was not correlated to HOMA-IR. However, WMLs was negatively correlated with left hippocampal volume (Spearman's rho=-.208, p=.02). WMLs volume was positively correlated with age and with serum triglyceride levels and negatively correlated with serum HDL cholesterol levels.
Conclusion(s): In this study in a non-diabetic AD population, white matter lesions were not correlated with peripheral insulin resistance. This suggests that in non-diabetic AD subjects, vascular changes are not influenced by peripheral insulin resistance.
Copyright © 2019 RN - 50-99-7 (glucose); 84778-64-3 (glucose); 204656-20-2 (liraglutide)
MIDER Authors
Citations
Altmetric:
Date
2019-07-14
Type
Conference Proceeding
Subject
Alzheimer Disease, Diabetes Mellitus, Drug Therapy, Magnetic Resonance Imaging, Drug Resistance
Collections
Citation
Junaid K, Does insulin resistance influence white matter lesions in non-diabetic AD subjects? Alzheimer's Association International Conference; 2019 14-18 July; California, United States. Chicago: Elsevier; July 2019. p.1064-1065.
Journal / Source Title
Alzheimer's and Dementia
DOI
PMID
Publisher
Elsevier
Publisher’s URL
Publisher’s statement
This is a conference abstract from the Alzheimer's Association International Conference 2019 in Los Angeles, California from 14-18 July 2019.